These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report. Ishiwatari A; Wakai S; Shirakawa H; Honda K Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399 [TBL] [Abstract][Full Text] [Related]
5. Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy. Barbari A; Chehadi R; Kfoury Assouf H; Kamel G; Jaafar M; Abdallah A; Rizk S; Masri M Exp Clin Transplant; 2017 Jun; 15(3):350-354. PubMed ID: 28367758 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599 [TBL] [Abstract][Full Text] [Related]
7. Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab. Weclawiak H; Ribes D; Guilbeau-Frugier C; Touchard G; Kamar N; Mehrenberger M; Modesto A; Rostaing L Clin Nephrol; 2008 May; 69(5):373-6. PubMed ID: 18538101 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab. Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233 [TBL] [Abstract][Full Text] [Related]
9. Single-dose rituximab for recurrent glomerulonephritis post-renal transplant. Spinner ML; Bowman LJ; Horwedel TA; Delos Santos RB; Klein CL; Brennan DC Am J Nephrol; 2015; 41(1):37-47. PubMed ID: 25634230 [TBL] [Abstract][Full Text] [Related]
10. The pathology and clinical features of early recurrent membranous glomerulonephritis. Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329 [TBL] [Abstract][Full Text] [Related]
11. Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population. Anjum N; Nabi Z; Alam MA J Ayub Med Coll Abbottabad; 2019; 31(2):265-268. PubMed ID: 31094128 [TBL] [Abstract][Full Text] [Related]
13. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. Kearney N; Podolak J; Matsumura L; Houghton D; Troxell M Transplant Proc; 2011 Dec; 43(10):3743-6. PubMed ID: 22172838 [TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent, post-kidney transplant membranoproliferative glomerulonephritis with plasmapheresis and rituximab: A case report and literature review . Yango AF; Fischbach BV; Ruiz R; Mudrovich S; Klintmalm G Clin Nephrol; 2019 Jan; 91(1):52-58. PubMed ID: 30431428 [TBL] [Abstract][Full Text] [Related]
15. The Beneficial Role Of Anti-Phospholipase A2 Receptor Auto-Antibodies And Rituximab In The Management Of Recurrent Primary Membranous Nephropathy After Kidney Transplantation. Anjum N; Nabi Z J Ayub Med Coll Abbottabad; 2021; 33(2):315-318. PubMed ID: 34137554 [TBL] [Abstract][Full Text] [Related]